Established firmly on such manufacturing principles as miniaturization, modularization, systems integration, parallelism, and redundancy, these technologies promise to vastly reduce the cost of drug development, accelerate the rate of human genomics research, and enable new modes of analysis of analytes not easily measured and at sites previously unprecedented.
Early stage commercial activity has seen the emergence of several high-technology-based start-up companies. A number of these are well funded post IPO (Initial Pubic Offering) companies, while many more are armed with technology licenses, collaborative research agreements, and aggressive R&D; strategies hoping to define their niche in what promises to be a worldwide $B20 market by 2010. As with all rapidly emerging technologies, alliances are being forged between universities, national laboratories and small and large companies.
|
Our Mission
An
integrative research and education enterprise that is oriented toward
service, is actively managed and directed by the constituency it
serves, and is focused on providing leadership and excellence to the
scientific and technological area of bioelectronics, biosensors and
biochips.
|
Our Vision
To integrate
teaching, research, scholarship and service across the traditional
disciplines and across Life Sciences and Humanities, the College of
Engineering and Science and the College of Business and Behavioral
Science.
To focus on the interface of chemistry, microelectronics, materials science, biology and medical technology defined by bioelectronics, biosensors, and biochips. |
|
|
||||
|
||||